Vyne Therapeutics Inc (NASDAQ:VYNE)

1.14
Delayed Data
As of Oct 22
 -0.02 / -1.72%
Today’s Change
1.08
Today|||52-Week Range
13.20
-81.96%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Vyne Therapeutics Inc have a median target of 4.00, with a high estimate of 10.00 and a low estimate of 3.00. The median estimate represents a +250.88% increase from the last price of 1.14.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Vyne Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.31
Sales
$4.8M
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.38%
 
 
 
 
 
 
Growthannually 56.40%
 
 
 
 
 
 

Sales

Growthquarterly 11.82%
 
 
 
 
 
 
Growthannually -13.10%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.